Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The endogenous cannabinoid (eCB) system represents a major therapeutic target for the treatment of a variety of anxiety-related disorders. A recent study has demonstrated that pharmacologic or genetic disruption of CB1-receptor-mediated neurotransmission decreases the extinction of conditioned fear in mice. Here, we examined whether CB1 blockade would similarly disrupt extinction in rats, using fear-potentiated startle as a measure of conditioned fear. We also examined whether pharmacologic enhancement of CB1 activation would lead to enhancements in extinction. Our results indicate that systemic administration of the CB1 antagonist rimonabant (SR141716A) prior to extinction training led to significant, dose-dependent decreases in extinction. While the administration of the CB1 agonist WIN 55,212-2 did not appear to affect extinction, administration of AM404, an inhibitor of eCB breakdown and reuptake, led to dose-dependent enhancements in extinction. In addition to showing decreased fear 1 and 24 h after extinction training, AM404-treated animals showed decreased shock-induced reinstatement of fear. Control experiments demonstrated that the effects of AM404 could not be attributed to alterations in the expression of conditioned fear, locomotion, shock reactivity, or baseline startle, as these parameters seemed unchanged by AM404. Furthermore, coadministration of rimonabant with AM404 blocked this enhancement of extinction, suggesting that AM404 was acting to increase CB1 rece…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The endocannabinoid system has also been implicated in conditioned fear extinction and represents an additional area of exploration for facilitating extinction and prevention of fear return.”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Chhatwal et al. (83) showed that enhanced cannabinoid receptor CB1 activation (via administration of AM404, an agent that prevents endocannabinoid degradation and reuptake) facilitated within-session and between-session extinction of fear-potentiated startle as well as reinstatement in mice (83).”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Activating CB1R via systemic or intra-hippocampal or -mPFC administration of either the CB1R agonist, WIN55212-2, the ECB reuptake blocker, AM404, or AEA itself has been shown to facilitate rodent fear extinction, in most cases without affecting conditioned fear [89,95–98] (but see [90]).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [96]
Citations
Cites
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“Recent studies of CB1 knockout mice have demonstrated that the genetic deletion of the CB1 receptor leads to increased anxiety in several well-studied measures (Haller et al, 2002, 2004a, b; Martin et al, 2002).”
BackgroundRole of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 3×
“Manipulation of the endogenous cannabinoid (eCB) system has become a major focus of current research, especially in the search for novel therapeutics to treat many common mental illnesses, including anxiety disorders, depression, and drug addiction (Porter and Felder, 2001; Kathuria et al, 2003).”
BackgroundResultKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 2×
“…by the dense expression of the CB1 receptor in regions known to be important for anxiety and emotional learning, including the amygdala, hippocampus, and throughout the mesolimbic dopamine reward system (Katona et al, 1999, 2000, 2001; Freund et al, 2003; van der Stelt and Di Marzo, 2003).”
BackgroundResultMemory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
Suzuki, A., Josselyn, S. A., Frankland, P. W., Masushige, S., Silva, A. J., & Kida, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-03.2004 · Cited by 1,127
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 1×
“Follow-up clinical trials have now demonstrated that this approach may be successful in humans as well (Ressler et al, 2004; Rothbaum and Davis, 2003).”
BackgroundSelf-citationMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 1×
“These hybridization results are in close agreement with previous studies using immunohistochemical and hybridization techniques (Katona et al, 1999; Marsicano and Lutz, 1999; McDonald and Mascagni, 2001).”
ResultBehavioral and Neural Analysis of Extinction
Myers, K. M., & Davis, M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01064-4 · Cited by 918 · cited 1×
“Reinstatement of fear is one of the principle behavioral processes upon which the idea is based that extinction does not lead to an ‘erasure’ of memory, but rather to a parallel inhibitory process that masks the previous fear memory (for a review, see Myers and Davis, 2002).”
BackgroundSelf-citationWalker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Self-citation
Cited by
Items 201–300 of 417
Posttraumatic stress disorder and traumatic stress: from bench to bedside, from war to disaster
Ursano, R. J., Goldenberg, M., Zhang, L., Carlton, J. R., Fullerton, C. S., Li, H., Johnson, L. R., & Benedek, D. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05721.x · Cited by 43
Papini, S., Sullivan, G. M., Hien, D. A., Shvil, E., & Neria, Y. (2015) · Biological Psychology · doi:10.1016/j.biopsycho.2014.10.010 · Cited by 36
Hammoud, M. Z., Peters, C., Hatfield, J. R. B., Gorka, S. M., Phan, K. L., Milad, M. R., & Rabinak, C. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0416-6 · Cited by 42
Batista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 42
Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders
Vinod, K. Y., & Hungund, B. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.203 · Cited by 42
Sachser, R. M., Crestani, A. P., Quillfeldt, J. A., Souza, T. M. E., & Alvares, L. D. O. (2015) · Learning & Memory · doi:10.1101/lm.039891.115 · Cited by 42
Reich, C. G., Iskander, A. N., & Weiss, M. S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499207 · Cited by 40
Post-traumatic stress disorder: emerging concepts of pharmacotherapy
Baker, D. G., Nievergelt, C. M., & Risbrough, V. B. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902972494 · Cited by 40
The genetics of anxiety‐related negative valence system traits
Savage, J. E., Sawyers, C., Roberson‐Nay, R., & Hettema, J. M. (2017) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32459 · Cited by 36
Wrubel, K. M., Barrett, D. W., Shumake, J., Johnson, S. E., & Gonzalez-Lima, F. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.08.009 · Cited by 39
Rovira-Esteban, L., Gunduz‐Cinar, O., Bukalo, O., Limoges, A., Brockway, E. T., Müller, K., Fenno, L. E., Kim, Y. S., Ramakrishnan, C., Andrási, T., et al. (2019) · eNeuro · doi:10.1523/eneuro.0220-19.2019 · Cited by 38
Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze.
Komaki, A., Hashemi-Firouzi, N., Shojaei, S., Souri, Z., Heidari, S., & Shahidi, . (2015) · PubMed Central · Cited by 38
Fear Erasure Facilitated by Immature Inhibitory Neuron Transplantation
Yang, W., Liu, T., Cao, J.-W., Chen, X.-F., Liu, X., Wang, M., Su, X., Zhang, S., Qiu, B., Hu, W., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.11.018 · Cited by 37
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 37
Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety
Murkar, A., Koninck, J. D., & Merali, Z. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.002 · Cited by 37
Gorka, S. M., Phan, K. L., Lyons, M., Mori, S., Angstadt, M., & Rabinak, C. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.359 · Cited by 35
Chronic cannabis use is associated with impaired fear extinction in humans.
Papini, S., Ruglass, L. M., Lopez-Castro, T., Powers, M. B., Smits, J. A. J., & Hien, D. A. (2017) · Journal of Abnormal Psychology · doi:10.1037/abn0000224 · Cited by 32
Wise, L. E., Harloe, J. P., & Lichtman, A. H. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.06.001 · Cited by 34
Suplita, R. L., Eisenstein, S. A., Neely, M. H., Moise, A. M., & Hohmann, A. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.006 · Cited by 33
Lester, K. J., Coleman, J. R. I., Roberts, S., Keers, R., Breen, G. D., Bögels, S. M., Creswell, C., Hudson, J. L., McKinnon, A., Nauta, M. H., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32467 · Cited by 33
Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?
Ney, L. J., Crombie, K. M., Mayo, L. M., Felmingham, K. L., Bowser, T. A., & Matthews, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.040 · Cited by 33
Goonawardena, A. V., Sesay, J., Sexton, C. A., Riedel, G., & Hampson, R. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.003 · Cited by 31
Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation
Glatt, C. E., & Lee, F. S. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.020 · Cited by 30
Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test
Barbano, M. F., Castañé, A., Martín‐García, E., & Maldonado, R. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1557-9 · Cited by 30
Behavioral Neurobiology of the Endocannabinoid System
Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 29
Fattore, L., Piva, A., Zanda, M. T., Fumagalli, G. F., & Chiamulera, C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4793-4 · Cited by 29
de Bitencourt, R. M., Takahashi, R. N., & Carlini, E. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638032 · Cited by 28
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
Kwee, C., Leen, N. A., der Kamp, R. C. V., Lissa, C. J. V., Cath, D. C., Groenink, L., & Baas, J. M. P. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.001 · Cited by 28
Amphetamine and extinction of cued fear
Carmack, S. A., Wood, S. C., & Anagnostaras, S. G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.049 · Cited by 27
Corticosteroid–endocannabinoid loop supports decrease of fear-conditioned response in rats
de Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.010 · Cited by 27
Neuroanatomical substrates involved in cannabinoid modulation of defensive responses
Moreira, F. A., Aguiar, D., Resstel, L. B. M., Lisboa, S. F. D. S., Campos, A. C., Gomes, F. V., & Guimarães, F. S. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400651 · Cited by 27
Genetic disruptions of Drosophila Pavlovian learning leave extinction learning intact
Qin, H., & Dubnau, J. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00548.x · Cited by 27
Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis
Pinna, G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00482 · Cited by 26
Powers, M. S., Barrenha, G. D., Mlinac, N. S., Barker, E. L., & Chester, J. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1997-2 · Cited by 26
Goodman, J., & Packard, M. G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.007 · Cited by 25
Cold pressor test improves fear extinction in healthy men
Antov, M. I., Melicherova, U., & Stockhorst, U. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.009 · Cited by 24
Neuropeptide receptors as potential pharmacological targets for obesity
Meneguetti, B. T., Cardoso, M. H. E. S., Ribeiro, C. F. A., Felício, M. R., Pinto, I. B., Santos, N. C., Carvalho, C. M. E., & Franco, O. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.002 · Cited by 26
Loflin, M., Babson, K. A., Sottile, J. E., Norman, S. B., Gruber, S. A., & Bonn‐Miller, M. O. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1604722 · Cited by 25
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 24
Ney, L. J., Nichols, D. S., & Lipp, O. V. (2023) · Psychophysiology · doi:10.1111/psyp.14297 · Cited by 24
Zabik, N. L., Rabinak, C. A., Peters, C. A., & Iadipaolo, A. S. (2023) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2023.107758 · Cited by 24
Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers
Marin, M., Lonak, S. F., & Milad, M. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0582-0 · Cited by 24
Bennett, M. R., Arnold, J. C., Hatton, S. N., & Lagopoulos, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.11.029 · Cited by 23
Effect of the Endocannabinoid System in Memory Updating and Forgetting
Lunardi, P. S., Souza, L. W., dos Santos, B. D., Popik, B., & Alvares, L. D. O. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.045 · Cited by 21
Mizuno, I., & Matsuda, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00246-y · Cited by 21
Chapter 16 Endocannabinoid System and Fear Conditioning
Resstel, L. B. M., Moreira, F. A., & Guimarães, F. S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81016-9 · Cited by 21
Perna, G., Daccò, S., Menotti, R., & Caldirola (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s12979 · Cited by 21
Manteghi, F., Nasehi, M., & Zarrindast, M. (2017) · EXCLI journal · doi:10.17179/excli2016-693 · Cited by 21
Yamada, D., Yanagisawa, S., Yoshizawa, K., Yanagita, S., Oka, J., Nagase, H., & Saitoh, A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107792 · Cited by 21
Sütt, S. (2010) · DSpace repository (University of Tartu) · Cited by 21
INQUIRY INTO USE OF CANNABIS FOR MEDICAL PURPOSES
Hall, W., & Farrell, M. (2013) · Cited by 20
Anxiety Modulation by Cannabinoids—The Role of Stress Responses and Coping
Haller, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115777 · Cited by 20
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning
Nasehi, M., Davoudi, K., Ebrahimi-Ghiri, M., & Zarrindast, M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.034 · Cited by 20
Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights
Bedard‐Gilligan, M. A., Lehinger, E. A., Cornell-Maier, S., Holloway, A., & Zoellner, L. A. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00414-x · Cited by 20
Ghasemi, M., Abrari, K., Goudarzi, I., & Rashidy‐Pour, A. (2017) · Basic and Clinical Neuroscience Journal · doi:10.29252/nirp.bcn.8.6.493 · Cited by 19
Bedse, G., Centanni, S. W., Winder, D. G., & Patel, S. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14159 · Cited by 19
In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction
Warren, W. G., Papagianni, E. P., Stevenson, C. W., & Stubbendorff, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15200 · Cited by 19
Translational fear inhibition models as indices of trauma-related psychopathology
D. Norrholm, S., & Jovanovic, T. (2011) · Current Psychiatry Reviews · doi:10.2174/157340011797183193 · Cited by 17
Iglesias, L. P., Fernandes, H. D. B., de Miranda, A. S., Pérez, M. M., Faccioli, L. H., Sorgi, C. A., Bertoglio, L. J., de Aguiar, D. C., Wotjak, C. T., & Moreira, F. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109314 · Cited by 17
Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear
Bisby, M. A., Richardson, R., & Baker, K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109834 · Cited by 17
Uzuneser, T. C., Szkudlarek, H. J., Jones, M., Nashed, M. G., Clement, T., Wang, H., Ojima, I., Rushlow, W. J., & Laviolette, S. R. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac220 · Cited by 16
Moore, N. L. T., Gauchan, S., & Genovese, R. F. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.01.011 · Cited by 16
Anastasio, T. J. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00074 · Cited by 16
Role of Cannabinoid Receptors in Anxiety Disorders
Degroot, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_24 · Cited by 16
Physiology of the Amygdala: Implications for PTSD
Rainnie, D. G., & Ressler, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-329-9_3 · Cited by 16
Self-citationMcCallum, A. L., Limebeer, C. L., & Parker, L. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.010 · Cited by 15
The Effect of Δ9-Tetrahydrocannabinol on the Extinction of an Adverse Associative Memory
Ashton, J. C., Smith, P. F., & Darlington, C. L. (2007) · Pharmacology · doi:10.1159/000107663 · Cited by 15
Danan, D., Todder, D., Zohar, J., & Cohen, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126416 · Cited by 14
The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential
Finn, D. P., Viveros, M., & Marco, E. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111428526 · Cited by 14
Groenink, L., Verdouw, P. M., Zhao, Y., ter Heegde, F., Wever, K. E., & Bijlsma, E. Y. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06307-1 · Cited by 13
Distinct pathways for norepinephrine‐ and opioid‐triggered antinociception from the amygdala
Maire, J. J., Close, L. N., Heinricher, M. M., & Selden, N. R. W. (2015) · European Journal of Pain · doi:10.1002/ejp.708 · Cited by 13
Targeting the endocannabinoid system to treat haunting traumatic memories
Akirav, I. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00124 · Cited by 13
Extinction, spontaneous recovery and reinstatement in the garden snail, Helix aspersa
Álvarez, B., Morís, J., Luque, D., & Loy, I. (2014) · Animal Behaviour · doi:10.1016/j.anbehav.2014.03.023 · Cited by 13
Aliczki, M., Barna, I., Till, I., Baranyi, M., Sperlágh, B., Goldberg, S. R., & Haller, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4219-8 · Cited by 13
Zabik, N. L., Iadipaolo, A. S., Peters, C. A., Baglot, S. L., Hill, M. N., & Rabinak, C. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06702-w · Cited by 12
Scienza-Martin, K., Lotz, F. N., Zanona, Q. K., Santana, F., Crestani, A. P., Boos, F. Z., Calcagnotto, M. E., & Quillfeldt, J. A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.009 · Cited by 12
Manwell, L. A., & Mallet, P. E. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3798-5 · Cited by 12
Pickens, C. L., & Theberge, F. R. M. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000020 · Cited by 12
PET Imaging of Endocannabinoid System
Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 12
Extinction learning of rewards in the rat: is there a role for CB1 receptors?
Hernández, G., & Cheer, J. F. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2275-7 · Cited by 12
Höfelmann, D., Benedetto, B. D., Azad, S. C., Micale, V., Wotjak, C. T., & Rammes, G. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.011 · Cited by 11
Jones, M. J., Uzuneser, T. C., Clement, T., Wang, H., Ojima, I., Rushlow, W. J., & Laviolette, S. R. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06468-7 · Cited by 10
Velikova, M., Doncheva, D., & Tashev, R. E. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-025 · Cited by 10
Fear acquisition and extinction in elderly patients with depression
Rainer, C., Nasrouei, S., Tschofen, S., Bliem, H. R., Wilhelm, F. H., & Marksteiner, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.044 · Cited by 10
Learning and Memory During Sleep and Anesthesia
Reasor, J. D., & Poe, G. R. (2008) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e318181e513 · Cited by 10
Ney, L. J., Akóṣílè, W., Davey, C. G., Pitcher, L., Felmingham, K. L., Mayo, L. M., Hill, M. N., & Strodl, E. S. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2276309 · Cited by 9
Recent Developments in Anxiety Disorders
Christmas, D. M. B., & Hood, S. D. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906778773625 · Cited by 9
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 8
Chapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
The Hippocampal Endocannabinoid System in Different Memory Phases: Unveiling the CA1 Circuitry
Quillfeldt, J. A., & Alvares, L. D. O. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_3 · Cited by 7
The Endocannabinoid System in the Control of Behavior
Gómez, E. S., Metna‐Laurent, M., Bellocchio, L., Busquets-García, A., & Marsicano, G. (2017) · Wiley eBooks · doi:10.1002/9781118540770.ch13 · Cited by 7
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Ney, L. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125527 · Cited by 6
Obi, T., & Ressler, K. J. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02371-9 · Cited by 7
Self-citationMuzik, O., Mann, T., Kopchick, J. J., Chowdury, A., Yacou, M. A., Vadgama, J., Bonello, D., & Diwadkar, V. A. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100035 · Cited by 6
Gerhard, D. M., Tse, N., Lee, F. S., & Meyer, H. C. (2023) · Developmental Psychobiology · doi:10.1002/dev.22409 · Cited by 6
Translating findings from basic fear research to clinical psychiatry in Puerto Rico.
Quirk, G. J., Martínez, K., & Nazario, L. L. (2007) · PubMed · Cited by 6
Fast and slow extinction pathways in defensive survival circuits
Orederu, T. A., & Schiller, D. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.06.004 · Cited by 6
ASPECTOS NEUROBIOLÓGICOS IMPLICADOS EN EL MIEDO ANIMAL
Sánchez-Ramírez, J. D., & Uribe-Velásquez, L. F. (2009) · Repositorio Universidad de Caldas · Cited by 6
Mechanisms of Fear Extinction: Toward Improved Treatment for Anxiety
Barad, M., & Cain, C. K. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511500008.008 · Cited by 6
Fischer, A., & Tsai, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-329-9_4 · Cited by 6
Metadata
- Authors
- Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J.
- Affiliations
- Emory University (US)
- Corresponding author
- Ressler, Kerry J
- Venue
- Neuropsychopharmacology
- Published
- 2004-12-22
- Volume
- 30
- Issue
- 3
- Pages
- 516-524
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987096289
- Cited by
- 376
- References
- 49
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 20 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 19 · 2015: 24 · 2014: 26 · 2013: 23 · 2012: 14
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (MH47840)
- National Institute of Mental Health (MH 47840, F30MH070218, MH070218, MH69884, K01MH069884)
- National Institute of General Medical Sciences (T32GM008169)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, fear-potentiated startle, rimonabant, AM404, WIN 55,212-2, fear extinction, anxiety disorders, post-traumatic stress disorder, fear reconsolidation, emotional learning, exposure therapy
- MeSH terms
- Amygdala, Animals, Extinction, Psychological, Fear, Male, Synaptic Transmission, Rats, Sprague-Dawley, In Situ Hybridization, Receptor, Cannabinoid, CB1, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.